9
2022Evoke Mind+Matter
AGENCY STATEMENT
We create meaningful experiences to create meaningful change. We are 250 passionate experts—world-class thinkers, scientists, and doers pushing the boundaries of craft and expertise. Our full-service teams are based on both the east and west coast of the US and across 4 locations in the UK.

- Agency description
At Evoke Mind+Matter our mission is to create meaningful experiences to create meaningful change.
And, driving real, measurable behaviour change is at the heart of what we do, day in day out.
Our team of 250 passionate experts—world-class thinkers, scientists, and doers – push the boundaries of craft and expertise. Our offering covers the full spectrum marketing and communications, using insight driven creativity to inspire behaviour change across multiple channels and audiences.
Our full-service teams are based on both the east and west coast of the US and across 4 locations in the UK. We’re a full-service agency that do it all. Just not like everyone else!
So what makes us distinct?
- A health first, sector second approach that ensures what we learn in one sector, makes us more innovative, creative and impactful in another
- Proven behavioural science that delivers measurable real-world outcomes
- Strategic omnichannel planning to ensure relevant engagement with our audiences
- Data driven insight, medical and scientific capability alongside deep channel expertise
- Courageous creative inspired by the courage of the communities we serve
At the core of the Evoke Mind+Matter proposition is our planning model CHANGE, a behavioural science-led strategic methodology co-created with the internationally recognised Centre for Behaviour Change at UCL.
We partner with clients from big pharma to consumer wellness. New clients can expect:
- A dedicated onboarding programme that goes beyond ways of working
- A clear project management methodology that uses the latest tools to ensure we deliver on time and within budget
- Regular account health checks to celebrate what’s working well and iron out any wrinkles to ensure we build for the future
- Regular investment in you and your business
And we can prove it!
- We’re proud of our 4.5/5 annual client health check score
- The majority of our clients have worked with us for five years or more
- 80% of our new business comes from existing clients
Solving the biggest challenges in health is not for the faint of heart, unless you’re a Matter Maker. To discuss how you can deliver measurable change get in touch mindplusmatter@evokegroup.com.
Let’s do something meaningful together!
- Contact details
- Sovereign House, Church Street Brighton East Sussex, BN1 1UJ
- 01273712000
- mindplusmatter@evokegroup.com
- https://www.evokegroup.com/evoke-mind-plus-matter
- Key contact
- Abi Stevenson
- Senior Business Development Manager
- abi.stevenson@evokegroup.com
- 01273712000
- 2022 Agency Data
-
2021 awardsTotal staff250-499 staffBillings from UK creative healthcare workHealthcare staff250-499 staffTotal agency billingsAgency ageBetween 1 and 2 yearsSocial media footprintStatusNETWORKEDApproximate percentage of advertising, branding, creative or design work in the UK healthcare market30-39%
- This information was supplied or confirmed by Evoke Mind+Matter. Bar charts are indicative only, with 100% being the maximum score allocated across all agencies. Billings from UK creative healthcare work are not a subset of total annual billings, and so may show a higher rating.
- Ranking factors contributing to agency score
- This chart shows the relative factors that contributed to the agency's overall ranking.
- Awards
- Communique Awards
Winner - Excellence in multi-channel campaigns for Why Sit it Out CSL Behring
PM Society Awards
Winner - Creative Culture Awards
Finalist - Effectiveness – Patient Communications - Why sit it out CSL Behring
Finalist - Patient Support - GSK Severe Asthma/GAAPP survey and guide
VMA's Winner - Integrated Digital Campaign Award– BEAT Canine Heart Disease for Boehringer Ingelheim
Highly Commended - London Vet Show @ Home campaign for Elanco
Highly Commended - Companion Animal Advertising Award - Dronspot for Elanco
Highly Commended - B2C support campaign – ThankUVets for Boehringer Ingelheim
Influencer Marketing Awards
Finalist - Best Cause-Led Campaign - Mind+Matter: Superdrug Faces of the Future
Purpose Awards
Finalist - Collaboration - Best Health Cause Campaign - Canesten, Different is Normal - This may contain additional awards supplied by Evoke Mind+Matter that were not included when generating this year’s T40 - please see methodology to find out which awards schemes were included.
Latest content from Evoke Mind+Matter on PMHub
- Personalized Oncology: Calling for a New Kind of Partnership:
- In the 1990s, biomarkers were the future of personalized medicine and a “lab on a chip” was the holy grail of understanding patient health. As much as past predictions of whole organ transplants and intra-body cameras have been realized, the notion of using measuring an array of protein to better understand a patient’s individual health, current and future, has still eluded us. But maybe for not much longer.
Evoke Mind+Matter - EVOKE STRENGTHENS LEADERSHIP TEAM IN EUROPE TO DELIVER MORE INTEGRATED CLIENT SOLUTIONS
- *Corrina Safeio, promoted to Group Managing Director taking on responsibility for Evoke London and Evoke Mind+Matter *Lee Wales, promoted to Deputy Managing Director at Evoke Mind+Matter UK *Holly Ford, promoted to Head of Consumer Communications at Evoke Mind+Matter UK
Evoke Mind+Matter - EVOKE MIND+MATTER BOLSTERS SENIOR TEAM WITH TRIO OF STRATEGIC HIRES
- *Mohinder Mann joins as Associate Medical Director *Nicole Moores joins as Associate Director, Pharma & Lifesciences *Sharron Woods joins as Associate Director, Animal Health Evoke Mind+Matter has continued to strengthen its global marcomms offering with the addition of three strategic associate level hires.
Evoke Mind+Matter



COVID-19 Updates and Daily News
-
Pharmacovigilance Project Lead
- Highly competitive salary
-
Pharmacovigilance Manager
- Highly competitive salary
- Strategy Director - Healthcare Advertising
- Highly competitive salary
-
Technical Sales Representative
- Highly competitive salary
-
Senior Medical Writer
- Highly competitive salary
-
Omnichannel Account Director
- £55,000 - £65,000 yearly
- Early Access Program - Regulatory Affairs (EAP-RA)
- Highly competitive salary
- Associate Director - Global Healthcare Consulting
- Highly competitive salary
Quick links
Latest intelligence
- Improving cardiovascular disease care and awareness
- Scott Curley talks to PME about the risks of CVD and the importance of getting the right treatment at the right time...
- Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease......
- Paul Hutchings, founder of fox&cat, writes on the role of humour in healthcare comms: PharmaComms 2023...
- MHRA to introduce new UK clinical trials framework
- AbbVie’s Parkinson’s disease therapy application rejected by FDA
- Roche and Eli Lilly to collaborate on Alzheimer’s disease blood test
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- FDA proposes improvements for oncology clinical trials supporting accelerated approval
- Novo Nordisk and Dewpoint partner on insulin resistance drug candidates
- MSD’s Keytruda to be made available in England for advanced cervical cancer patients
- Boehringer Ingelheim and Covant to collaborate on cancer immunotherapies
- Eli Lilly increases investment to almost $1bn for new Irish manufacturing facility
- Regeneron and Sonoma partner on autoimmune disease therapies
- Improving cardiovascular disease care and awareness
- PMGroup announces launch of new recruitment platform PharmaRole
- Team ITG appoints Gerhard Arnhofer as head of customer strategy for life sciences division
- Locus Biosciences announces first patient treated in urinary tract infection trial
- The state of pharma customer experience
- MHRA to introduce new UK clinical trials framework
- Takeda presents positive phase 2b results for TAK-279 in plaque psoriasis
- Sanofi/Regeneron’s Dupixent approved by EC for atopic dermatitis in children